Recruiting
Study of LY3410738 in Patients with Advanced Solid Cancer Tumors with a Change in the IDH1 or IDH2 Gene
I9Y-OX-JDHC - ClinicalTrials.gov - NCT04521686
The main purpose of this study is to learn more about the safety, side effects, and early effectiveness of LY3410738. LY3410738 may be used to treat solid cancer tumors that have a change in a particular gene (known as the IDH gene).
How long will I be in the trial?
Participation could last up to 2 years and possibly longer if the disease does not get worse.
Recruiting
Study of LY3410738 in Patients with Advanced Solid Cancer Tumors with a Change in the IDH1 or IDH2 Gene
I9Y-OX-JDHC - ClinicalTrials.gov - NCT04521686
The main purpose of this study is to learn more about the safety, side effects, and early effectiveness of LY3410738. LY3410738 may be used to treat solid cancer tumors that have a change in a particular gene (known as the IDH gene).
How long will I be in the trial?
Participation could last up to 2 years and possibly longer if the disease does not get worse.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Have an advanced solid tumor cancer with a change in the IDH1 or IDH2 gene
Have stopped cancer treatment
Be well enough to perform their own personal care
Have adequate organ function and blood counts, as measured by blood tests
Participants must NOT
Have an active infection or any serious medical conditions (other than cancer)
Have cancer that has spread to the brain or spinal cord and is causing symptoms
Have any problems absorbing food or medicine taken by mouth
Be taking certain medicines that affect how fast the study drug is broken down in the body
Be pregnant or breast-feeding during the study or within 90 days after the last dose of study drug
Trial Summary
Conditions the trial is for
Sarcoma, Advanced Cancer, Biliary Tract Cancer, Solid Tumor, Brain Cancer
What the trial is testing?
LY3410738
Could I receive a Placebo?
no
Enrollment Goal
180
Trial Dates
October 2020 - February 2023
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Have an advanced solid tumor cancer with a change in the IDH1 or IDH2 gene
Have stopped cancer treatment
Be well enough to perform their own personal care
Have adequate organ function and blood counts, as measured by blood tests
Participants must NOT
Have an active infection or any serious medical conditions (other than cancer)
Have cancer that has spread to the brain or spinal cord and is causing symptoms
Have any problems absorbing food or medicine taken by mouth
Be taking certain medicines that affect how fast the study drug is broken down in the body
Be pregnant or breast-feeding during the study or within 90 days after the last dose of study drug
Trial Summary
Conditions the trial is for
Sarcoma, Advanced Cancer, Biliary Tract Cancer, Solid Tumor, Brain Cancer
What the trial is testing?
LY3410738
Could I receive a Placebo?
no
Enrollment Goal
180
Trial Dates
October 2020 - February 2023
Trial Phase
1
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy
Resources
